High-Dose Chemotherapy with Early Autologous Stem Cell Transplantation Compared to Standard Dose Chemotherapy or Delayed Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis
Open Access
- 20 September 2018
- journal article
- review article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 25 (2), 239-247
- https://doi.org/10.1016/j.bbmt.2018.09.021
Abstract
No abstract availableKeywords
Funding Information
- Celgene
- Amgen
- Bayer
- Novartis
- Bristol-Myers Squibb
This publication has 40 references indexed in Scilit:
- Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trialHaematologica, 2007
- Diagnostic evaluation of t(4;14) in multiple myeloma and evidence for clonal evolutionLeukemia, 2007
- High-dose Therapy with Single Autologous Transplantation versus Chemotherapy for Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-analysis of Randomized Controlled TrialsTransplantation and Cellular Therapy, 2007
- Standard Chemotherapy Compared With High-Dose Chemoradiotherapy for Multiple Myeloma: Final Results of Phase III US Intergroup Trial S9321Journal of Clinical Oncology, 2006
- High-Dose Therapy and Autologous Blood Stem-Cell Transplantation Compared With Conventional Treatment in Myeloma Patients Aged 55 to 65 Years: Long-Term Results of a Randomized Control Trial From the Group Myelome-AutogreffeJournal of Clinical Oncology, 2005
- High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMABlood, 2005
- Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trialBlood, 2004
- Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysisBone Marrow Transplantation, 2003
- Measuring inconsistency in meta-analysesBMJ, 2003
- Clinical and biologic implications of recurrent genomic aberrations in myelomaBlood, 2003